Stock Market Trends Based on Machine Learning: Returns up to 338.38% in 1 Year

Stock Market Trends

This stock market trends forecast is part of the Risk-Conscious Package, as one of I Know First’s equity research solutions. We determine our aggressive stock picks by screening our algorithm daily for higher volatility stocks that present greater opportunities but are also riskier. The full Risk-Conscious Package includes a daily forecast for a total of 40 stocks divided into four main categories:

  • Top 10 Aggressive stocks for the long position
  • Top 10 Aggressive stocks for the short position
  • Top 10 Conservative stocks for the long position
  • Top 10 Conservative stocks for the short position


Package Name: Aggressive Stocks Forecast
Recommended Positions: Long
Forecast Length: 1 Year (11/25/2018 – 11/25/2019)
I Know First Average: 82.75%
Stock Market Trends
Stock Market Trends chart

For this 1 Year forecast the algorithm had successfully predicted 9 out of 10 movements. The top-performing prediction in this forecast was ARWR, which registered a return of 338.38%. The suggested trades for ARRY and ACAD also had notable 1 Year yields of 205.95% and 158.02%, respectively. The Aggressive Stocks Forecast package had an overall average return of 82.75%, providing investors with a premium of 63.72% over the S&P 500’s return of 19.03%.

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company’s therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more proteins. The Company’s preclinical pipeline of RNA interference (RNAi) therapeutics includes both subcutaneously administered liver-targeted candidates and extra-hepatic candidates. The Company’s pre-clinical-stage drug candidates include ARO-HBV, ARO-AAT, ARO-LPA, ARO-AMG1, ARO-F12 and ARO-HIF2.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.